To embed, copy and paste the code into your website or blog:
As I said back in October, delivering a successful Covid-19 vaccine quickly was a huge challenge, but the diversity of the UK’s vaccine portfolio and the amendments made to the Human Medicines Regulations 2012 (
HMRs) meant that the UK was in a strong position to carry out a successful mass vaccination programme as soon as a vaccine could demonstrate its safety, quality and efficacy. Six months later, two vaccines have been widely administered in the UK (AstraZeneca/Oxford and Pfizer/BioNTech) – as of 3 April 2021, 31,523,010 first doses and 5,381,745 second doses have been administered. A third vaccine is also now available (Moderna).